Daiichi-Ranbaxy has tied up with Canada-based transdermal drug development firm Nuvo Research Inc to supply a topical wound healing agent Oxoferin in some Asian countries.

Venus Remedies has received patents from South Africa for its antibiotic combination product Potentox.

Matrix Laboratories, a subsidiary of Mylan Inc, has received final approval for lansoprazole delayed-release capsules from the US Food and Drug Administration.

Unlike Viagra, flibanserin works on the brain to rekindle sexual appetite in women

Indinavir, anti HIV drug from Ranbaxy Laboratories Limited has been included pre-qualification list of  the World Health Organisation, Geneva (WHO), the company announced.